The assessment of the impact of thrombocytopenia symptoms on the patients’ daily activities with the use of TSIDAV vignette
Journal Title: JOURNAL OF HEALTH POLICY & OUTCOMES RESEARCH - Year 2016, Vol 9, Issue 1
Abstract
Objective: Assessment of the impact of thrombocytopenia symptoms on patients’ daily activities using vignettes. Methods: Vignettes were used to collect information from adult patients and children’s caregivers in order to assess the impact of thrombocytopenia symptoms on patients’ daily activities. Each vignette consisting of two parts aimed at collecting qualitative information about major health problems related to thrombocytopenia symptoms and at measuring the intensity of the symptoms’ impact on daily activities in a quantitative way. Descriptive part collected patients’ qualitative information about symptoms influencing their daily functioning or those bothering them the most. Quantitative part using Likert scale assessed the impact of specific symptoms on patients’ lives. Results: We collected 61 questionnaires from 31 women, 17 men, 13 children’s caregivers. Among men the biggest impact on activities was observed in relation to petechiae and easy bruising (both symptoms were declared as significant by 29% of respondents). 68% women considered skin and mucosa petechiae, 65% indicated easy bruising and 52% bleeding from gums and nose as having significant impact on daily activities. 62% of parents or caregivers believed that petechiae and mucosa had significant impact on the performance of the children’s daily activities, same significance was referenced to easy bruising (54%) and bleeding from gums and nose (42%). Conclusions: Thrombocytopenia symptoms influence patients’ daily activities and the most frequently mentioned symptoms influencing those across all groups were petechiae and easy bruising. According to the calculated vignettes values the highest impact on daily activity of the symptoms was indicated for children.
Authors and Affiliations
Monika Szkultecka-Dębek, Mariola Drozd, Małgorzata Nowakowska, Marta Bem, Nina Wiśniewska, Joanna Mazur
Keywords
Related Articles
- EP ID EP192269
- DOI 10.7365/JHPOR.2016.1.6
- Views 66
- Downloads 0
Drug policy as an integral part of state health policy - international examples
Medicines policy plays a major role in protecting, maintaining and restoring people’s health and is an integral part of state health policy. It embraces brand and generic drugs, biologics, vaccines and natural health pro...
Contracts for providing publically funded outpatient medical services - criteria for tenders evaluation as a tool of health policy in Poland
he Polish health care system is essentially divided into three basic levels of service: basic health care, outpatient specialist care, hospital treatment. Since 2003 the payer is the National Health Fund. Medical facilit...
Idiopathic Pulmonary Fibrosis as a Challenge for the Polish Healthcare System
Idiopathic pulmonary fibrosis (IPF) is a rare disease characterised by age-dependent incidence, unclear aetiology and progressive course. Given the complexity of the diagnostic pathway and limited therapeutic options, an...
Telemedicine - a miracle cure for everything?
Background: Telemedicine is an interesting area of modern treatment. It enables contact between patients and doctors at long distance. In this paper, we present the latest studies, conducted among Polish doctors about th...
Adoption of Real World Evidence in decision-making processes on public funding of drugs in Poland
Background: The aim of the study was to assess the use and impact of RWE in decision-making processes on public funding of drugs in Poland. Methods: The analysis was based on data from the Agency for Health Technology A...